Sarah Solomon

729 total citations
11 papers, 531 citations indexed

About

Sarah Solomon is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Infectious Diseases. According to data from OpenAlex, Sarah Solomon has authored 11 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Gastroenterology and 3 papers in Infectious Diseases. Recurrent topics in Sarah Solomon's work include Sarcoma Diagnosis and Treatment (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (3 papers). Sarah Solomon is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (3 papers). Sarah Solomon collaborates with scholars based in United States. Sarah Solomon's co-authors include Andrew J. Wagner, Jeffrey A. Morgan, Suzanne George, Jeffrey T. Yap, Margaret von Mehren, James E. Butrynski, Annick D. Van den Abbeele, Edwin Choy, Jonathan A. Fletcher and Michael C. Heinrich and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Sarah Solomon

11 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Solomon United States	9	364	251	199	100	79	11	531
Yasuo Hosouchi Japan	15	209 0.6×	130 0.5×	221 1.1×	197 2.0×	41 0.5×	41	580
Caio Rocha-Lima United States	10	271 0.7×	206 0.8×	315 1.6×	289 2.9×	30 0.4×	12	609
Toshiro Okuyama Japan	14	321 0.9×	145 0.6×	174 0.9×	211 2.1×	14 0.2×	32	605
Matías Chacón Argentina	13	191 0.5×	79 0.3×	192 1.0×	100 1.0×	24 0.3×	56	429
Y-K. Kang South Korea	15	476 1.3×	177 0.7×	454 2.3×	229 2.3×	21 0.3×	39	749
Akiko Nishitani Japan	14	434 1.2×	439 1.7×	68 0.3×	363 3.6×	118 1.5×	24	686
Joanna Huszno Poland	11	146 0.4×	76 0.3×	193 1.0×	61 0.6×	13 0.2×	37	425
Isabel Alvarado Mexico	11	110 0.3×	74 0.3×	262 1.3×	196 2.0×	11 0.1×	20	457
Katsuhiko Ehi Japan	14	366 1.0×	184 0.7×	172 0.9×	249 2.5×	6 0.1×	25	574
Mathias Hoiczyk Germany	10	218 0.6×	111 0.4×	128 0.6×	114 1.1×	41 0.5×	20	386

Countries citing papers authored by Sarah Solomon

Since Specialization

Citations

This map shows the geographic impact of Sarah Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Solomon more than expected).

Fields of papers citing papers by Sarah Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Solomon. The network helps show where Sarah Solomon may publish in the future.

Co-authorship network of co-authors of Sarah Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Solomon. A scholar is included among the top collaborators of Sarah Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Solomon. Sarah Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Suárez‐Fueyo, Abel, Sean J. Bradley, Takayuki Katsuyama, et al.. (2018). Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype. The Journal of Immunology. 200(9). 3077–3086. 17 indexed citations

Kamran, Sophia C., Suzanne George, Jeffrey A. Morgan, et al.. (2017). Whole exome analysis of patients (pts) with metastatic GIST (mGIST) demonstrating exceptional survival with imatinib (IM) therapy compared to those with short term benefit.. Journal of Clinical Oncology. 35(15_suppl). 11513–11513. 1 indexed citations

Ben‐Ami, Eytan, Constance M. Barysauskas, Sarah Solomon, et al.. (2017). Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. Cancer. 123(17). 3285–3290. 163 indexed citations

Ben‐Ami, Eytan, Constance M. Barysauskas, Margaret von Mehren, et al.. (2016). Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy. Annals of Oncology. 27(9). 1794–1799. 82 indexed citations

George, Suzanne, Constance M. Barysauskas, Sarah Solomon, et al.. (2016). Phase 2 study of nivolumab in metastatic leiomyosarcoma of the uterus.. Journal of Clinical Oncology. 34(15_suppl). 11007–11007. 13 indexed citations

George, Suzanne, Yang Feng, Margaret von Mehren, et al.. (2013). Prolonged survival and disease control in the academic phase II trial of regorafenib in GIST: Response based on genotype.. Journal of Clinical Oncology. 31(15_suppl). 10511–10511. 9 indexed citations

George, Suzanne, Qian Wang, Michael C. Heinrich, et al.. (2012). Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial. Journal of Clinical Oncology. 30(19). 2401–2407. 200 indexed citations

Zhang, Hongwang, Mervi Detorio, Brian D. Herman, et al.. (2011). Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3′-azido-2′,3′-dideoxypurine nucleosides. European Journal of Medicinal Chemistry. 46(9). 3832–3844. 11 indexed citations

Koontz, Dianna, Ghazia Asif, Hongwang Zhang, et al.. (2011). The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 55(8). 3758–3764. 2 indexed citations

10.

George, Suzanne, Margaret von Mehren, Michael C. Heinrich, et al.. (2011). A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU).. Journal of Clinical Oncology. 29(15_suppl). 10007–10007. 22 indexed citations

11.

Zhang, Hongwang, Steven J. Coats, Franck Amblard, et al.. (2009). Synthesis and evaluation of 3′-azido-2′,3′-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus. Bioorganic & Medicinal Chemistry Letters. 20(1). 60–64. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact